Enliven Partners LLC, a leading Bay Area-based real estate investment and development firm, has announced the successful $9.15 million acquisition of a 30-unit apartment community ...

The company is juggling a lawsuit filed by the Round Table Owners Association and potential bankruptcy as franchisees demand ...

Enliven Therapeutics jumped on strong ELVN-001 phase 1b CML data, but a rich valuation may cap upside. Click here to read an ...

Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.

United States equity markets closed mixed as sector divergence shaped major indices, highlighting contrasting movement across ...

A Supreme Court ruling on tariffs and the U.S. jobs report were scheduled for Friday. ・Housing, biotech and aviation stocks ...

Enliven Therapeutics recently reported positive preliminary results from the first phase of a clinical trial for its chronic ...

Enliven Therapeutics' stock rose after early trial results showed strong responses and good safety for its leukemia drug, ...

Stocks are mixed as defense stocks surge, with the Dow Jones Industrial Average (DJI) up triple digits, while the Nasdaq Composite (IXIC) slides alongside tech ...

Enliven Therapeutics (EVN) stock jumps as the company post initial early-stage trial data for its lead asset ELVN-001 in ...

Shares of Enliven Therapeutics (NASDAQ:ELVN) climbed 7% on Thursday after the company released positive early results from a ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...